Recently, a Leu309Met mutation in WKL1 (MLC1, KIAA0027), a gene mapped to chromosome 22q13.33, was reported to co-segregate with periodic catatonia, a clinical sub-type of schizophrenia, in seven members of an extended pedigree.
Schizophrenia is a common complex disorder that affects approximately 1% of the world's population. 2 Linkage studies have provided evidence for the involvement of many chromosomal regions including: 1q21-22, 1q32-41, 4q31, 5p13-14, 5q22-31, 6p22-24, 6q21-22, 8p21-22, 9q21-22, 10p11-15, 13q14-32, 15q15, 22q11-13, and Xp11. [3] [4] [5] [6] [7] [8] [9] [10] [11] Evidence from most studies support genetic heterogeneity. Several efforts have been reported to identify genetically more homogenous subgroups of families with schizophrenia. [11] [12] [13] In an attempt to reduce genetic heterogeneity, Stober and coworkers restricted a genome wide linkage study to detect schizophrenia susceptibility loci to 12 German families ascertained through a proband who met criteria for periodic catatonia as defined by Leonhard. 11, 14 Evidence for linkage was obtained in these pedigrees (average 4.8 affected individuals per pedigree) for chromosome 15q15 at D15S1012 (nonparametric LOD score (NPL) = 3.57, P = 2.6 × 10 ) and chromosome 22q13 at D22S1169 (NPL = 1.85; P = 1.8 × 10 −3 ). The majority of the evidence for linkage to the 22q13 region came from one extended large pedigree with seven affected subjects. Further genotyping narrowed the region of interest to D22S1160-telomere (4 cM).
1 Screening for nucleotide variants in 22 available family members and in 327 unrelated controls identified a single missense mutation (Leu309Met) in the WKL1 gene which co-segregates with periodic catatonia in the seven affected individuals and obligate carriers in the pedigree. Six unaffected family members carried two wild-type alleles. 1 The mutation was not detectable in controls nor in three additional catatonia families exhibiting the same chromosome 22-specific haplotypes (D22S1161-D22S526). 1 In addition to the putative dominantly acting missense mutation in a family with periodic catatonia reported by Meyer et al, a recent report implicates homozygous loss-of-function mutations in WKL1 as causative of the severe neurodegenerative disorder megaencephalic leukoencephalopathy with subcortical cysts (MIM 604004). 15 Should these disorders be proven to be allelic, an understanding of the pathophysiology of schizophrenia would surely be forthcoming.
In 1998, Blouin et al reported the results of a genome-wide scan of 54 mostly European Caucasian multiplex schizophrenia pedigrees (Johns Hopkins pedigrees). 6 Significant evidence for schizophrenia susceptibility loci on chromosome 13q32 and suggestive evidence for chromosome 8p21 were reported. Other regions with non-parametric linkage evidence P-values Ͻ0.01 included chromosomes 7q, 14q, and 22q. For chromosome 22q the maximum NPL was 2.42 (P = 0.009) at 22q11 (D22S1265). A subgroup of families was identified where the affecteds in the families exhibited excess allele sharing in the 22q13 region.
The present study was undertaken to follow up the
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report of an association of a mutation in WKL1 (chromosome 22q13.3; cDNA is Genbank No. AF319633) with catatonic schizophrenia (MIM 181500). 1 We screened WKL1 for etiological mutations in 28 probands from the Johns Hopkins pedigrees who were given a consensus diagnosis of schizophrenia and met at least one of these criteria: (1) were from families where affected individuals with schizophrenia were reported to display catatonic behavior sometime during the course of their illness; or (2) were from families exhibiting excess allele sharing among affected family members for markers in the 22q13 region. We believe that if this mutation is important to a clinical subtype of schizophrenia (individuals exhibiting catatonic symptoms), these criteria limited the proband sample in such a way as to increase the probability of detecting a mutation, ie, they shared the phenotype of interest and/or were from families where linkage analysis identified the chromosomal region as being involved in susceptibility. In addition to screening the 28 probands from the Johns Hopkins pedigree collection, 15 German probands were similarly screened. These 15 probands (from 15 pedigrees) all exhibited catatonic schizophrenia, 1 yet had weak evidence for linkage to 22q13. The Leu309Met positive proband was also screened as a positive control.
The WKL1 gene spans ෂ26 Mb and is comprised of 12 exons (based on comparison of GenBank accession numbers AF319633 for the cDNA and AL022327 for the genomic PAC clone RP3-355C18). The 3.6 kb mRNA encodes a putative non-selective neuronal cation channel. The initiation codon of the gene is located in exon 2. The WKL1 protein has 377 amino acid residues and structure analysis of the protein has revealed 6-8 putative transmembrane domains. 1 The highest identity scores were obtained for the shaker-related human voltage-gated potassium channel KCNA1 followed by other members of this extended gene family; however, characteristic features such as the voltage sensor in S4 and the selectivity filter in the P region are missing or poorly conserved.
1 Therefore, WKL1 may represent a novel subfamily of genes distantly related to non-selective ion channels or ion-dependent transporters. While WKL1 is an ideal candidate for causing schizophrenia based on function and one putative mutation, its role remains to be validated.
We used denaturing high performance liquid chromatography (DHPLC) to analyze all of the coding sequence of the WKL1, intron/exon boundaries, and a portion of the 3ЈUTR. DHPLC has a sensitivity of 95% in our hands as well as in reports in the literature. [16] [17] [18] [19] When heteroduplexes were identified, those amplimers were sequenced from patients and compared to controls to identify nucleotide changes. The screening of WKL1 identified a large number of SNPs that included 15 SNPs occurring in the non-coding regions of the gene, three SNPs in the 3ЈUTR, four synonymous coding SNPs (cSNPs) and two non-synonymous (amino acid changing) cSNPs. The allele frequencies and positions of the SNPs within WKL1 are presented in Figure  1 . The two non-synonymous cSNPs (C7997T and T21349C) identified were excluded as causative by screening 80 outbred USA population controls (160 chromosomes) by DHPLC. The C7997T polymorphism had a population heterozygosity of 21.8%, and the T21349C had a population heterozygosity of 23.8%. Thus, neither of these amino acid changes could cause the phenotype in the catatonia patients. We identified the Leu309Met mutation in the appropriate proband but not in any other patient samples, and thus feel comfortable with our mutation detection sensitivity (we have previously shown this technique to identify one nucleotide mutation out of Ͼ20000 bp in 9/10 probands). 16, 17 Of interest is sample JHU-14 which is completely homozygous for all WKL1 SNPs. This may suggest deletion of one allele (hemizygosity), particularly since there is enriched homozygosity for a number of contiguous rare alleles at the 3Ј end of the gene. We are currently following up this finding by looking at dosage, but as there have been no reports of an excess of schizophrenia among the megalencephalic leukoencephalopathy families that show loss-of-function mutations of WKL1 (ie carriers), this is unlikely to be the case. No additional missense (or nonsense) mutations were identified in any other probands in our collective cohort.
WKL1 can be ruled out as contributing to the cause of schizophrenia in 28 Johns Hopkins and 15 University of Wuerzburg samples of schizophrenia probands from multiplex families, however, the chromosome 22q13 region remains a candidate region for future studies in other sample sets. Failure to detect a mutation in WKL1 in these probands does not negate the hypothesized causal role WKL1 may play in the previously studied German pedigree.
Materials and methods

Clinical
Johns Hopkins probands Twenty-eight probands from multiplex schizophrenia families were included in these analyses (see Blouin et al, 1998, 6 for details of ascertainment, evaluation, and diagnostic procedures). Probands with schizophrenia were selected for these analyses if they met at least one of the following criteria: (1) affected individuals in the pedigree exhibited allele sharing for the 22q13 region when haplotypes from GeneHunter 2.0 analyses were examined (n = 18); 20 (2) the individual was from a family where at least two schizophrenic subjects had catatonic behavior rated as present, ie, based on the available evidence, the diagnosticians thought that the individuals had displayed catatonic behavior sometime during the course of his/her illness (n = 10). These probands had not been included in the prior genome scan linkage studies. Two of the probands selected on the basis of allele sharing status in the chromosome 22q13 region also had a positive history of catatonia. The majority of the probands were of European Caucasian ancestry (n = 25) and male (n = 23). Their age-at-onset for schizophrenia ranged from age 12-33 (mean age Figure 1 Visual SNP genotypes of WKL1 in the 43 schizophrenia probands. All SNPs which were identified (along the horizontal axis) in the schizophrenic probands (along the vertical axis) are illustrated as boxes of either: blue, which represent homozygosity for the common allele; red, a heterozygous individual; or yellow, which represent homozygosity for the rare allele. The nomenclature of the SNP identifiers indicates which is the common allele (before the base position) and which is the rare allele (after the base position). Base position numbering refers to the genomic sequence from Genbank No. AL022327. SNP identifiers are color-coded to represent: SNPs in the non-coding region of the gene (green), SNPs that are synonymous and occur in the coding region of the gene (yellow), and SNPs that are non-synonymous (amino acid changing) in the coding region of the gene (red). The bottom of the figure has the allele frequencies for the rare allele across the 43 probands. Sample numbers along the vertical preceded with 'JHU' are from the Johns Hopkins proband cohort 6 and sample numbers preceded with 'UW' are from University of Wuerzburg cohort. 11 The red sample (UW-34) is a positive control sample with a Leu309Met amino acid change.
1 DHPLC can often not discriminate between homozygous individuals for a common allele and those homozygous for a rare allele, and thus the frequency of homozygous individuals for the rare allele may be an underestimate. Of interest is proband JHU-14, who appears to be completely homozygous across the gene, in particular for a number of rare SNPs at the 3Ј end of the gene.
years). The study has been approved by the Johns Hopkins University School of Medicine Institutional Review Board (IRB)
University of Wuerzburg probands Fifteen affected subjects from 15 multiplex families were ascertained as previously described. 1, 11 The study was approved by the Ethics Committee of the University of Wuerzburg and all individuals participated after giving written consent.
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Mutation analysis
Genomic DNA was extracted from patient samples as previously described. 11, 21 Exons of the WKL1 gene were amplified using primers developed by Meyer et al with minor modifications. 1 The primer sequences are available at www. Mutation screening was performed using denaturing high performance liquid chromatography (DHPLC) to identify single base changes. The HPLC system used was the Wave DNA fragment analysis system with a DNASep column that has a stationary phase consisting of 2-m nonporous alkylated (C 18 ) poly(styrenedivinylbenzene) particles, a UV detector set at 260 nm, and an autosampler with the capacity to handle 96 samples (Transgenomic, San Jose, CA, USA). The two eluents used for analysis on the HPLC system are (A) 0.1 M triethylammoniumacetate (TEAA) and (B) 0.1 M TEAA/25% acetonitrile. PCR products from above (10 l per sample) were eluted at a flow rate of 0.9 ml min −1 with a linear acetonitrile gradient. The elution gradient and melting temperature predictions were determined by WAVEMAKER software (Transgenomic). The separation gradient (%B per min) for analysis was adjusted to elute the amplicon between 3.5 and 6.5 min ( Figure  1 ) and were analyzed at multiple column temperatures to ensure heteroduplex detection. Optimal run temperatures were empirically determined on the basis of each fragment's characteristic melting profile and the analysis column temperatures are located at www.med.jhu.edu/epigen. Data analysis was based on comparison with a normal control included in the analysis of each exon. Heterozygote profiles are detected as distinct from homozygous wild-type elution profiles. All samples were analyzed independently (as opposed to with a normal DNA spike). Non-synonymous SNPs C7997T and T21349C were screened by DHPLC on a set of 80 outbred USA controls to determine heterozygosity indexes in controls using the identical column conditions as were used to identify the SNPs.
Sequencing analysis
Amplicons that showed heteroduplexes, as compared to controls, were sequenced to identify the base change. PCR products were electrophoresed through a 2% agarose gel, bands were cut from the gel and purified using the QIAquick Gel Extraction Kit (Qiagen, Valencia, CA, USA). 20 ng of pure PCR product was sequenced in each direction using the identical primers used for the initial PCR with BigDye  Terminator 2.0 Kit (Applied Biosystems) according to the manufacture's instructions. After the sequencing reaction, the products were purified using ethanol precipitation. Samples were analyzed on an ABI PRISM  3100 Genetic Analyzer (Applied Biosystems). Nucleotide changes were identified by aligning sequence generated from both primers (forward and reverse) for comparison with corresponding wild-type sequence and Genbank No. AL022327 using SEQUENCHER 4.0.2 analysis software (Gene Codes, Ann Arbor, MI, USA).
